Page 88 - TD-4-2

Tumor Discovery DRGs in HCC prognosis and immunity

associated expression pattern in breast cancer based on 20. Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics,
machine learning. Front Genet. 2023;14:1193944. 2022. CA Cancer J Clin. 2022;72(1):7-33.
doi: 10.3389/fgene.2023.1193944 doi: 10.3322/caac.21708
10. Li M, Wang J, Zhao Y, et al. Identifying and evaluating a 21. Tang Y, Zhang Y, Hu X. Identification of potential hub genes
disulfidptosis-related gene signature to predict prognosis related to diagnosis and prognosis of hepatitis B virus-related
in colorectal adenocarcinoma patients. Front Immunol. hepatocellular carcinoma via integrated bioinformatics
2024;15:1344637. analysis. Biomed Res Int. 2020;2020:4251761.
doi: 10.3389/fimmu.2024.1344637 doi: 10.1155/2020/4251761
11. Li XM, Liu SP, Li Y, Cai XM, Zhang SB, Xie ZF. Identification 22. Xu K, Zhang Y, Yan Z, et al. Identification of
of disulfidptosis-related genes with immune infiltration in disulfidptosis related subtypes, characterization of tumor
hepatocellular carcinoma. Heliyon. 2023;9(8):e18436. microenvironment infiltration, and development of DRG
prognostic prediction model in RCC, in which MSH3 is a key
doi: 10.1016/j.heliyon.2023.e18436 gene during disulfidptosis. Front Immunol. 2023;14:1205250.
12. Wada F, Koga H, Akiba J, et al. High expression of CD44v9 and doi: 10.3389/fimmu.2023.1205250
xCT in chemoresistant hepatocellular carcinoma: Potential
targets by sulfasalazine. Cancer Sci. 2018;109(9):2801-2810. 23. Zhang C, Zhang X, Dai S, Yang W. Exploring prognosis
and therapeutic strategies for HBV-HCC patients based on
doi: 10.1111/cas.13728 disulfidptosis-related genes. Front Genet. 2024;15:1522484.
13. Koppula P, Zhuang L, Gan B. Cystine transporter SLC7A11/ doi: 10.3389/fgene.2024.1522484
xCT in cancer: Ferroptosis, nutrient dependency, and cancer
therapy. Protein Cell. 2021;12(8):599-620. 24. Ai J, Huang H, Lv X, et al. FLNA and PGK1 are two potential
markers for progression in hepatocellular carcinoma. Cell
doi: 10.1007/s13238-020-00789-5 Physiol Biochem. 2011;27(3-4):207-216.
14. Zhu JH, De Mello RA, Yan QL, et al. MiR-139-5p/SLC7A11 doi: 10.1159/000327946
inhibits the proliferation, invasion and metastasis of
pancreatic carcinoma via PI3K/Akt signaling pathway. 25. Patarat R, Riku S, Kunadirek P, et al. The expression of
Biochim Biophys Acta Mol Basis Dis. 2020;1866(6):165747. FLNA and CLU in PBMCs as a novel screening marker for
hepatocellular carcinoma. Sci Rep. 2021;11(1):14838.
doi: 10.1016/j.bbadis.2020.165747
doi: 10.1038/s41598-021-94330-1
15. Machesky LM. Deadly actin collapse by disulfidptosis. Nat 26. Li W, Li M, Liao D, et al. Carboxyl-terminal truncated HBx
Cell Biol. 2023;25(3):375-376. contributes to invasion and metastasis via deregulating
doi: 10.1038/s41556-023-01100-4 metastasis suppressors in hepatocellular carcinoma.
Oncotarget. 2016;7(34):55110-55127.
16. Zheng P, Zhou C, Ding Y, Duan S. Disulfidptosis: A new
target for metabolic cancer therapy. J Exp Clin Cancer Res. doi: 10.18632/oncotarget.10399
2023;42(1):103. 27. Li Y, Xu C, Sun B, Zhong F, Cao M, Yang L. Sema3d
doi: 10.1186/s13046-023-02675-4 restrained hepatocellular carcinoma progression through
inactivating Pi3k/Akt signaling via interaction with FLNA.
17. Ji PY, Li ZY, Wang H, Dong JT, Li XJ, Yi HL. Arsenic and Front Oncol. 2022;12:913498.
sulfur dioxide co-exposure induce renal injury via activation
of the NF-κB and caspase signaling pathway. Chemosphere. doi: 10.3389/fonc.2022.913498
2019;224:280-288. 28. Donadon M, Di Tommaso L, Soldani C, et al. Filamin
doi: 10.1016/j.chemosphere.2019.02.111 a expression predicts early recurrence of hepatocellular
carcinoma after hepatectomy. Liver Int. 2018;38(2):303-311.
18. Oduro PK, Zheng X, Wei J, et al. The cGAS-STING signaling
in cardiovascular and metabolic diseases: Future novel doi: 10.1111/liv.13522
target option for pharmacotherapy. Acta Pharm Sin B. 29. Sheng F, Chen KX, Liu J, et al. Chromium (VI) promotes
2022;12(1):50-75. EMT by regulating FLNA in BLCA. Environ Toxicol.
doi: 10.1016/j.apsb.2021.05.011 2021;36(8):1694-1701.
19. Hu FF, Liu CJ, Liu LL, Zhang Q, Guo AY. Expression doi: 10.1002/tox.23165
profile of immune checkpoint genes and their roles in 30. Ren Q, You Yu S. CD2-associated protein participates in
predicting immunotherapy response. Brief Bioinform. podocyte apoptosis via PI3K/Akt signaling pathway. J Recept
2021;22(3):bbaa176. Signal Transduct Res. 2016;36(3):288-291.
doi: 10.1093/bib/bbaa176 doi: 10.3109/10799893.2015.1101137

Volume 4 Issue 2 (2025) 80 doi: 10.36922/td.8214